In your interest.
Online Personal Finance Magazine
No beating about the bush.
Drug firm Cadila Healthcare Ltd said it launched a generic Pramipexole tablets, used for treating Parkinson's disease in the US market.
The company's subsidiary Zydus Cadila launched Pramipexole tablets in the strengths of 0.125mg, 0.25mg, 0.5mg, 1mg and 1.5mg, Cadila Healthcare said in a filing to Bombay Stock Exchange (BSE).
According to healthcare information solutions company, NDC Health, the sale of Pramipexole tablets in 2010 is estimated to be $632 million.
Pramipexole's patent, which has expired, was held by German drug maker Boehringer Ingelheim. Parkinson's disease is a progressive disorder marked by muscle rigidity, weakness, shaking, tremor, and eventually difficulty in walking and talking.
On Thursday, Cadila Healthcare shares ended 0.8% up at Rs694 on the Bombay Stock Exchange, while the benchmark Sensex closed 0.9% down to 20,497 points.